Home/Filings/4/0001096906-25-002142
4//SEC Filing

Hunter Robert Gail 4

Accession 0001096906-25-002142

CIK 0000318673other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 3:36 PM ET

Size

41.3 KB

Accession

0001096906-25-002142

Insider Transaction Report

Form 4
Period: 2025-11-28
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-11-28$3.92/sh+10,021$39,28266,178 total
  • Disposition to Issuer

    Class A Common Stock

    2025-11-28$8.64/sh4,547$39,28661,631 total
  • Award

    Director Stock Option (right to buy)

    2015-12-04$3.92/sh8,349$32,7280 total
    Exercise: $3.92From: 2016-03-04Exp: 2025-12-04Class A Common Stock (8,349 underlying)
  • Award

    Director Stock Option (right to buy)

    2015-12-07$3.92/sh1,672$6,5540 total
    Exercise: $3.92From: 2016-03-07Exp: 2025-12-07Class A Common Stock (1,672 underlying)
  • Award

    Director Stock Option (right to buy)

    2016-12-02$4.32/sh+7,952$34,3537,952 total
    Exercise: $4.32From: 2017-03-02Exp: 2026-12-02Class A Common Stock (7,952 underlying)
  • Award

    Director Stock Option (right to buy)

    2016-12-07$4.52/sh+1,590$7,1879,542 total
    Exercise: $4.52From: 2017-03-07Exp: 2026-12-07Class A Common Stock (1,590 underlying)
  • Award

    Director Stock Option (right to buy)

    2017-12-01$3.27/sh+1,514$4,95111,056 total
    Exercise: $3.27From: 2018-03-01Exp: 2027-12-01Class A Common Stock (1,514 underlying)
  • Award

    Director Stock Option (right to buy)

    2018-11-03$3.76/sh+8,657$32,55019,713 total
    Exercise: $3.76From: 2019-02-28Exp: 2028-11-30Class A Common Stock (8,657 underlying)
  • Award

    Director Stock Option (right to buy)

    2019-12-06$3.91/sh+8,242$32,22627,955 total
    Exercise: $3.91From: 2020-03-06Exp: 2029-12-26Class A Common Stock (8,242 underlying)
  • Award

    Director Stock Option (right to buy)

    2020-03-27$2.84/sh+7,850$22,29435,805 total
    Exercise: $2.84From: 2020-06-27Exp: 2030-03-27Class A Common Stock (7,850 underlying)
  • Award

    Director Stock Option (right to buy)

    2021-12-03$7.02/sh+7,293$51,19743,098 total
    Exercise: $7.02From: 2022-03-03Exp: 2031-12-03Class A Common Stock (7,293 underlying)
  • Award

    Director Stock Option (right to buy)

    2022-12-02$5.56/sh+8,104$45,05851,202 total
    Exercise: $5.56From: 2023-03-02Exp: 2032-12-02Class A Common Stock (8,104 underlying)
  • Award

    Director Stock Option (right to buy)

    2023-12-01$7.21/sh+8,820$63,59260,022 total
    Exercise: $7.21From: 2023-03-01Exp: 2033-12-01Class A Common Stock (8,820 underlying)
  • Award

    Director Stock Option (right to buy)

    2024-12-06$12.43/sh+10,920$135,73670,942 total
    Exercise: $12.43From: 2025-03-06Exp: 2034-12-06Class A Common Stock (10,920 underlying)
  • Award

    Director Stock Option (right to buy)

    2025-12-05$8.53/sh+10,400$88,71281,342 total
    Exercise: $8.53From: 2026-03-05Exp: 2035-12-05Class A Common Stock (10,400 underlying)
Footnotes (13)
  • [F1]This option was granted on December 4, 2015 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F10]This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F11]This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025.
  • [F12]This option was granted on December 6, 2024 as an option for 10,400 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $13.08 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
  • [F13]This option was granted on December 5, 2025 as an option for 10,400 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $8.53 per share. The options vest in quarterly installments beginning March 5, 2026.
  • [F2]This option was granted on December 7, 2015 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F3]This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F4]This option was granted on December 7, 2016 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.36 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F5]This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F6]This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F7]This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F8]This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F9]This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

Issuer

SECURITY NATIONAL FINANCIAL CORP

CIK 0000318673

Entity typeother

Related Parties

1
  • filerCIK 0001298091

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 3:36 PM ET
Size
41.3 KB